Quantum Biopharma Files 6-K, Incorporates Press Release
Ticker: QNTM · Form: 6-K · Filed: Sep 16, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Sep 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, press-release
TL;DR
Quantum Biopharma filed a 6-K on 9/16, referencing a 9/13 press release, tied to their F-3 filing.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on September 16, 2024, incorporating by reference a press release issued on September 13, 2024. This filing is part of their Registration Statement on Form F-3 (SEC File No. 333-276264). The company is incorporated in A6 and its fiscal year ends on December 31.
Why It Matters
This filing indicates ongoing reporting and updates from Quantum Biopharma, potentially related to its business activities or strategic developments, which are incorporated into its F-3 registration statement.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates a previously issued press release and is part of an existing registration statement, not indicating new material events.
Key Numbers
- 001-39152 — SEC File Number (Quantum Biopharma's SEC file number)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former Company Name
- September 13, 2024 (date) — Date of Press Release
- September 16, 2024 (date) — Filing Date
- 333-276264 (document_id) — Form F-3 Registration Statement File Number
FAQ
What is the title of the press release incorporated by reference in this 6-K filing?
The filing states that Exhibit 99.1 is a press release titled 'On September 13, 2024, Quantum BioPharma Ltd. issued a press release titled'.
What is the SEC file number for the Registration Statement on Form F-3 that this 6-K is incorporated into?
The SEC file number for the Registration Statement on Form F-3 is 333-276264.
When was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc.
What is the principal executive office address of Quantum Biopharma Ltd.?
The principal executive office is located at 199 Bay St., Suite 4000 Toronto, Ontario M5L 1A9, Canada.
On what date was the name change from FSD Pharma Inc. to Quantum Biopharma Ltd. effective?
The date of the name change was March 27, 2019.
Filing Stats: 228 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2024-09-16 07:27:55
Filing Documents
- fsd_6k.htm (6-K) — 10KB
- fsd_ex991.htm (EX-99.1) — 18KB
- 0001654954-24-011913.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: September 13, 2024 By: /s/ Donal Carroll Donal Carroll, Chief Financial Officer 3 EXHIBIT INDEX Exhibit Description Exhibit 99.1 Press Release dated September 13, 2024 4